Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Exchange | Industry | Zen Rating | Market Cap | Price | 1d % | EBITDA | P/E | D/E | Country | DD Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | NASDAQ | Biotechnology | $34.45B | $311.02 | 2.37% | $318.03M | 6,220.40x | 0.85 | Cayman Islands | ||
| CORT | CORCEPT THERAPEUTICS INC | NASDAQ | Biotechnology | $4.02B | $38.20 | 9.77% | $65.98M | 38.20x | 0.30 | United States | ||
| NVO | NOVO NORDISK A S | NYSE | Biotechnology | $232.79B | $52.39 | 2.97% | $24.81B | 14.57x | 2.02 | Denmark | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | NASDAQ | Biotechnology | $52.87B | $400.17 | 0.63% | $151.92M | 1,290.87x | 19.74 | United States | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | NASDAQ | Biotechnology | $3.18B | $42.01 | 1.83% | $53.58M | 85.72x | 0.33 | Bermuda | ||
| ZVRA | ZEVRA THERAPEUTICS INC | NASDAQ | Biotechnology | $469.52M | $8.34 | -6.92% | $67.21M | 17.38x | 1.03 | United States | ||
| VCEL | VERICEL CORP | NASDAQ | Biotechnology | $1.80B | $35.61 | -1.11% | $29.31M | 136.96x | 0.41 | United States | ||
| ARGX | ARGENX SE | NASDAQ | Biotechnology | $51.27B | $839.99 | -0.11% | $811.30M | 33.57x | 0.18 | Belgium | ||
| KRYS | KRYSTAL BIOTECH INC | NASDAQ | Biotechnology | $7.16B | $246.91 | 0.15% | $193.29M | 35.78x | 0.09 | United States | ||
| GMAB | GENMAB A | NASDAQ | Biotechnology | $20.43B | $31.82 | 3.31% | $2.00B | 13.58x | 0.22 | Denmark | ||
| TECH | BIO-TECHNE CORP | NASDAQ | Biotechnology | $9.29B | $59.65 | 1.43% | $220.90M | 119.30x | 0.29 | United States | ||
| LGND | LIGAND PHARMACEUTICALS INC | NASDAQ | Biotechnology | $3.74B | $190.11 | 0.55% | $103.01M | 82.30x | 0.55 | United States | ||
| ADMA | ADMA BIOLOGICS INC | NASDAQ | Biotechnology | $4.26B | $17.88 | -1.97% | $172.13M | 20.32x | 0.32 | United States | ||
| ABEO | ABEONA THERAPEUTICS INC | NASDAQ | Biotechnology | $287.76M | $5.31 | 0.76% | $89.85M | 3.34x | 0.35 | United States | ||
| MNKD | MANNKIND CORP | NASDAQ | Biotechnology | $1.72B | $5.60 | -1.23% | $73.18M | 56.00x | -12.10 | United States | ||
| VCYT | VERACYTE INC | NASDAQ | Biotechnology | $3.35B | $42.39 | 0.69% | $57.00M | 108.69x | 0.09 | United States | ||
| RPRX | ROYALTY PHARMA PLC | NASDAQ | Biotechnology | $22.43B | $38.86 | 0.57% | $1.04B | 22.08x | 1.01 | United States | ||
| CRMD | CORMEDIX INC | NASDAQ | Biotechnology | $958.07M | $12.16 | 4.56% | $112.26M | 5.36x | 1.01 | United States | ||
| NAGE | NIAGEN BIOSCIENCE INC | NASDAQ | Biotechnology | $498.79M | $6.25 | -1.73% | $22.69M | 23.15x | 0.39 | United States | ||
| EXEL | EXELIXIS INC | NASDAQ | Biotechnology | $11.68B | $43.58 | -0.57% | $927.60M | 17.72x | 0.31 | United States | ||
| VRTX | VERTEX PHARMACEUTICALS INC | NASDAQ | Biotechnology | $114.71B | $452.13 | -0.27% | $4.66B | 31.60x | 0.44 | United States | ||
| HALO | HALOZYME THERAPEUTICS INC | NASDAQ | Biotechnology | $8.27B | $70.31 | 4.47% | $845.48M | 14.38x | 3.41 | United States | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | NYSEMKT | Biotechnology | $139.93M | $1.74 | -3.33% | $8.87M | 24.86x | 0.56 | Israel | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | NASDAQ | Biotechnology | $11.42B | $59.45 | 0.03% | $772.70M | 21.86x | 0.26 | United States | ||
| APLS | APELLIS PHARMACEUTICALS INC | NASDAQ | Biotechnology | $3.27B | $25.86 | 2.95% | $93.37M | 73.89x | 1.64 | United States | ||
| AUPH | AURINIA PHARMACEUTICALS INC | NASDAQ | Biotechnology | $2.02B | $15.35 | -3.76% | $103.52M | 26.47x | 0.44 | Canada | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | NASDAQ | Biotechnology | $2.15B | $37.38 | -0.11% | $269.64M | 11.57x | 0.45 | United States | ||
| CPRX | CATALYST PHARMACEUTICALS INC | NASDAQ | Biotechnology | $2.85B | $23.15 | -0.81% | $323.88M | 12.93x | 0.14 | United States | ||
| MDXG | MIMEDX GROUP INC | NASDAQ | Biotechnology | $959.70M | $6.48 | -4.28% | $69.21M | 23.14x | 0.34 | United States | ||
| INVA | INNOVIVA INC | NASDAQ | Biotechnology | $1.49B | $19.87 | -0.60% | $214.76M | 10.51x | 0.42 | United States | ||
| REGN | REGENERON PHARMACEUTICALS INC | NASDAQ | Biotechnology | $81.59B | $776.31 | 0.58% | $5.71B | 17.87x | 0.30 | United States | ||
| UTHR | UNITED THERAPEUTICS CORP | NASDAQ | Biotechnology | $21.39B | $496.72 | 1.94% | $1.77B | 17.44x | 0.12 | United States | ||
| ACAD | ACADIA PHARMACEUTICALS INC | NASDAQ | Biotechnology | $4.45B | $26.29 | -1.57% | $287.72M | 16.75x | 0.45 | United States | ||
| INCY | INCYTE CORP | NASDAQ | Biotechnology | $19.91B | $101.42 | 2.68% | $1.68B | 16.79x | 0.36 | United States |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.